SLC37A1
gene geneOn this page
Also known as SPX1
Summary
SLC37A1 (solute carrier family 37 member 1, HGNC:11024) is a protein-coding gene on chromosome 21q22.3, encoding Glucose-6-phosphate exchanger SLC37A1 (P57057). Inorganic phosphate and glucose-6-phosphate antiporter.
The protein encoded by this gene localizes to the endoplasmic reticulum (ER) membrane. This protein translocates glucose-6-phosphate from the cytoplasm into the lumen of the ER for hydrolysis into glucose by another ER membrane protein. This gene is a member of the solute carrier 37 gene family. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 54020 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 137 total
- MANE Select transcript:
NM_001320537
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11024 |
| Approved symbol | SLC37A1 |
| Name | solute carrier family 37 member 1 |
| Location | 21q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SPX1 |
| Ensembl gene | ENSG00000160190 |
| Ensembl biotype | protein_coding |
| OMIM | 608094 |
| Entrez | 54020 |
Gene structure
Transcript identifiers
Ensembl transcripts: 32 — 27 protein_coding, 4 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000352133, ENST00000398341, ENST00000398343, ENST00000419522, ENST00000454800, ENST00000471277, ENST00000484887, ENST00000487951, ENST00000496416, ENST00000893151, ENST00000893152, ENST00000893153, ENST00000893154, ENST00000893155, ENST00000893156, ENST00000893157, ENST00000893158, ENST00000893159, ENST00000922856, ENST00000922857, ENST00000922858, ENST00000922859, ENST00000922860, ENST00000922861, ENST00000922862, ENST00000922863, ENST00000960757, ENST00000960758, ENST00000960759, ENST00000960760, ENST00000960761, ENST00000960762
RefSeq mRNA: 2 — MANE Select: NM_001320537
NM_001320537, NM_018964
CCDS: CCDS13689
Canonical transcript exons
ENST00000352133 — 20 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001050414 | 42534698 | 42534830 |
| ENSE00001050417 | 42563815 | 42563877 |
| ENSE00001050419 | 42542404 | 42542480 |
| ENSE00001050420 | 42535472 | 42535550 |
| ENSE00001050423 | 42539512 | 42539647 |
| ENSE00001050425 | 42525776 | 42525857 |
| ENSE00001050427 | 42547103 | 42547140 |
| ENSE00001050428 | 42579736 | 42579800 |
| ENSE00001050429 | 42558958 | 42559089 |
| ENSE00001050430 | 42543436 | 42543602 |
| ENSE00001050431 | 42564708 | 42564793 |
| ENSE00001138938 | 42513852 | 42514717 |
| ENSE00001296458 | 42554062 | 42554142 |
| ENSE00002439789 | 42562078 | 42562168 |
| ENSE00003509943 | 42568360 | 42568438 |
| ENSE00003531380 | 42565827 | 42565875 |
| ENSE00003534969 | 42574818 | 42574915 |
| ENSE00003614777 | 42518277 | 42518510 |
| ENSE00003689795 | 42566985 | 42567058 |
| ENSE00003845255 | 42580345 | 42581426 |
Expression profiles
Bgee: expression breadth ubiquitous, 199 present calls, max score 91.85.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0285 / max 151.2561, expressed in 1286 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189307 | 5.4739 | 1216 |
| 189308 | 1.0591 | 532 |
| 189309 | 1.0284 | 453 |
| 189313 | 0.2783 | 89 |
| 189311 | 0.0567 | 28 |
| 189312 | 0.0477 | 27 |
| 189306 | 0.0443 | 6 |
| 189310 | 0.0400 | 21 |
Top tissues by expression
266 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.85 | gold quality |
| left testis | UBERON:0004533 | 90.80 | gold quality |
| right uterine tube | UBERON:0001302 | 90.66 | gold quality |
| rectum | UBERON:0001052 | 90.59 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 90.56 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.26 | gold quality |
| right testis | UBERON:0004534 | 89.98 | gold quality |
| gall bladder | UBERON:0002110 | 89.36 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.11 | gold quality |
| small intestine | UBERON:0002108 | 89.09 | gold quality |
| transverse colon | UBERON:0001157 | 88.89 | gold quality |
| minor salivary gland | UBERON:0001830 | 88.33 | gold quality |
| pituitary gland | UBERON:0000007 | 88.20 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 87.49 | gold quality |
| duodenum | UBERON:0002114 | 87.13 | gold quality |
| cortical plate | UBERON:0005343 | 87.11 | gold quality |
| granulocyte | CL:0000094 | 86.95 | gold quality |
| testis | UBERON:0000473 | 86.85 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 86.57 | gold quality |
| body of stomach | UBERON:0001161 | 86.35 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.94 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 85.91 | gold quality |
| mouth mucosa | UBERON:0003729 | 85.66 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 85.44 | gold quality |
| monocyte | CL:0000576 | 85.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.29 | gold quality |
| mucosa of stomach | UBERON:0001199 | 85.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.92 | gold quality |
| esophagus mucosa | UBERON:0002469 | 84.92 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-6 | yes | 18.27 |
| E-MTAB-9067 | yes | 11.84 |
| E-ANND-3 | yes | 7.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting SLC37A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-488-3P | 99.61 | 68.79 | 1731 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
| HSA-MIR-5007-3P | 99.51 | 68.14 | 1242 |
| HSA-MIR-302A-5P | 99.39 | 68.21 | 1913 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-4711-3P | 98.97 | 66.87 | 1020 |
| HSA-MIR-367-5P | 98.84 | 67.18 | 902 |
| HSA-MIR-6761-5P | 98.71 | 68.03 | 1504 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-2117 | 98.48 | 67.97 | 1307 |
| HSA-MIR-550A-3P | 98.37 | 69.61 | 632 |
| HSA-MIR-4436B-3P | 98.25 | 65.26 | 1494 |
| HSA-MIR-6735-5P | 98.24 | 65.36 | 1488 |
| HSA-MIR-7843-5P | 98.12 | 65.26 | 1421 |
Literature-anchored findings (GeneRIF, showing 1)
- Data show that SLC37A1 and SLC37A2 are endoplasmic reticulum associated, P(i)-linked antiporters, that can transport glucose-6-phosphate. (PMID:21949678)
Cross-species orthologs
51 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc37a1 | ENSDARG00000086103 |
| mus_musculus | Slc37a1 | ENSMUSG00000024036 |
| rattus_norvegicus | Slc37a1 | ENSRNOG00000001169 |
| drosophila_melanogaster | dmGlut | FBGN0010497 |
| drosophila_melanogaster | MFS14 | FBGN0010651 |
| drosophila_melanogaster | Picot | FBGN0024315 |
| drosophila_melanogaster | CG9254 | FBGN0028513 |
| drosophila_melanogaster | CG6978 | FBGN0029727 |
| drosophila_melanogaster | VGlut | FBGN0031424 |
| drosophila_melanogaster | CG7881 | FBGN0033048 |
| drosophila_melanogaster | MFS12 | FBGN0033234 |
| drosophila_melanogaster | MFS15 | FBGN0034392 |
| drosophila_melanogaster | CG15096 | FBGN0034394 |
| drosophila_melanogaster | MFS16 | FBGN0034611 |
| drosophila_melanogaster | CG12490 | FBGN0034782 |
| drosophila_melanogaster | CG9825 | FBGN0034783 |
| drosophila_melanogaster | CG9826 | FBGN0034784 |
| drosophila_melanogaster | CG3649 | FBGN0034785 |
| drosophila_melanogaster | CG2003 | FBGN0039886 |
| drosophila_melanogaster | CG30265 | FBGN0050265 |
| drosophila_melanogaster | MFS1 | FBGN0050272 |
| caenorhabditis_elegans | WBGENE00001135 | |
| caenorhabditis_elegans | WBGENE00007669 | |
| caenorhabditis_elegans | WBGENE00008000 | |
| caenorhabditis_elegans | WBGENE00008677 | |
| caenorhabditis_elegans | WBGENE00010755 | |
| caenorhabditis_elegans | WBGENE00010931 | |
| caenorhabditis_elegans | WBGENE00011185 | |
| caenorhabditis_elegans | WBGENE00011556 | |
| caenorhabditis_elegans | WBGENE00012443 | |
| caenorhabditis_elegans | WBGENE00015271 | |
| caenorhabditis_elegans | WBGENE00015272 | |
| caenorhabditis_elegans | WBGENE00016003 | |
| caenorhabditis_elegans | WBGENE00018429 | |
| caenorhabditis_elegans | WBGENE00018918 | |
| caenorhabditis_elegans | WBGENE00018920 | |
| caenorhabditis_elegans | WBGENE00019187 | |
| caenorhabditis_elegans | WBGENE00019655 | |
| caenorhabditis_elegans | WBGENE00020583 | |
| caenorhabditis_elegans | WBGENE00020584 | |
| caenorhabditis_elegans | WBGENE00020697 | |
| caenorhabditis_elegans | WBGENE00020698 | |
| caenorhabditis_elegans | WBGENE00020699 | |
| caenorhabditis_elegans | WBGENE00020700 | |
| caenorhabditis_elegans | WBGENE00021157 | |
| caenorhabditis_elegans | WBGENE00021158 | |
| caenorhabditis_elegans | WBGENE00021219 | |
| caenorhabditis_elegans | WBGENE00021220 | |
| caenorhabditis_elegans | WBGENE00021223 | |
| caenorhabditis_elegans | WBGENE00021226 | |
| caenorhabditis_elegans | WBGENE00302978 |
Paralogs (12): SLC17A6 (ENSG00000091664), SLC17A9 (ENSG00000101194), SLC17A7 (ENSG00000104888), SLC17A2 (ENSG00000112337), SLC17A5 (ENSG00000119899), SLC17A3 (ENSG00000124564), SLC17A1 (ENSG00000124568), SLC37A2 (ENSG00000134955), SLC37A4 (ENSG00000137700), SLC17A4 (ENSG00000146039), SLC37A3 (ENSG00000157800), SLC17A8 (ENSG00000179520)
Protein
Protein identifiers
Glucose-6-phosphate exchanger SLC37A1 — P57057 (reviewed: P57057)
Alternative names: Glycerol-3-phosphate permease, Solute carrier family 37 member 1
All UniProt accessions (2): P57057, A0A0C4DG69
UniProt curated annotations — full annotation on UniProt →
Function. Inorganic phosphate and glucose-6-phosphate antiporter. May transport cytoplasmic glucose-6-phosphate into the lumen of the endoplasmic reticulum and translocate inorganic phosphate into the opposite direction. Independent of a lumenal glucose-6-phosphatase. May not play a role in homeostatic regulation of blood glucose levels.
Subcellular location. Endoplasmic reticulum membrane.
Tissue specificity. Expressed in numerous tissues, with highest expression in pancreas, kidney, bone marrow, spleen, liver, small intestine, as well as in fetal brain, liver and spleen.
Activity regulation. Inhibited by vanadate but not by chlorogenic acid.
Similarity. Belongs to the major facilitator superfamily. Organophosphate:Pi antiporter (OPA) (TC 2.A.1.4) family.
RefSeq proteins (2): NP_001307466, NP_061837 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000849 | Sugar_P_transporter | Family |
| IPR011701 | MFS | Family |
| IPR020846 | MFS_dom | Domain |
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
| IPR044740 | SLC37A1_2 | Family |
Pfam: PF07690
Catalyzed reactions (Rhea), 1 shown:
- D-glucose 6-phosphate(in) + phosphate(out) = D-glucose 6-phosphate(out) + phosphate(in) (RHEA:71535)
UniProt features (19 total): transmembrane region 12, glycosylation site 2, sequence variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P57057-F1 | 79.59 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 81, 263
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-70263 | Gluconeogenesis |
MSigDB gene sets: 150 (showing top):
GCANCTGNY_MYOD_Q6, GOZGIT_ESR1_TARGETS_DN, GOBP_INORGANIC_ANION_TRANSPORT, BOYLAN_MULTIPLE_MYELOMA_D_DN, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN, GOBP_PHOSPHATE_ION_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, REACTOME_GLUCONEOGENESIS, chr21q22, GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP, MYB_Q5_01, REACTOME_METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES
GO Biological Process (3): glucose-6-phosphate transport (GO:0015760), phosphate ion transmembrane transport (GO:0035435), transmembrane transport (GO:0055085)
GO Molecular Function (3): glucose 6-phosphate:phosphate antiporter activity (GO:0061513), antiporter activity (GO:0015297), transmembrane transporter activity (GO:0022857)
GO Cellular Component (4): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), endoplasmic reticulum (GO:0005783), organelle membrane (GO:0031090)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Glucose metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane transport | 2 |
| hexose phosphate transport | 1 |
| phosphate ion transport | 1 |
| transport | 1 |
| cellular process | 1 |
| glucose-6-phosphate transmembrane transporter activity | 1 |
| hexose-phosphate:phosphate antiporter activity | 1 |
| secondary active transmembrane transporter activity | 1 |
| transporter activity | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| membrane | 1 |
| membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1142 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC37A1 | HLA-F | P30511 | 464 |
| SLC37A1 | SLC16A5 | O15375 | 437 |
| SLC37A1 | PDE9A | O76083 | 424 |
| SLC37A1 | CSN1S1 | P47710 | 415 |
| SLC37A1 | SEL1L3 | Q68CR1 | 415 |
| SLC37A1 | RSPH1 | Q8WYR4 | 413 |
| SLC37A1 | MGST1 | P10620 | 412 |
| SLC37A1 | WSCD1 | Q658N2 | 398 |
| SLC37A1 | GPAT4 | Q86UL3 | 390 |
| SLC37A1 | ANKH | Q9HCJ1 | 388 |
| SLC37A1 | DGAT1 | O75907 | 384 |
| SLC37A1 | UBASH3A | P57075 | 364 |
| SLC37A1 | SLC45A3 | Q96JT2 | 356 |
| SLC37A1 | SLC26A2 | P50443 | 354 |
| SLC37A1 | SLC25A36 | Q96CQ1 | 353 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC37A1 | ADRB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SLC37A1 | GPR35 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SLC37A1 | GPR37 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SLC37A1 | HTR2B | psi-mi:“MI:0915”(physical association) | 0.370 |
| DCAF4 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC37A1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (93): SLC37A1 (Affinity Capture-RNA), SLC37A1 (Affinity Capture-MS), SLC37A1 (Two-hybrid), SLC37A1 (Two-hybrid), SLC37A1 (Two-hybrid), SLC37A1 (Two-hybrid), ABCA3 (Affinity Capture-MS), ACBD3 (Affinity Capture-MS), ACVR1B (Affinity Capture-MS), ADCY3 (Affinity Capture-MS), ADCY9 (Affinity Capture-MS), ATP6V0A2 (Affinity Capture-MS), AUP1 (Affinity Capture-MS), BIRC2 (Affinity Capture-MS), BMPR1A (Affinity Capture-MS)
ESM2 similar proteins: A0A2K2AIF4, A0A2K2BF92, A0A6P3HVI0, A1L272, A2SWM2, B8AF63, B9H7I1, B9N9Y7, E2RFJ3, E7EXX2, O02228, O54902, O77741, O80605, P41251, P49279, P49280, P49281, P49282, P51027, P56436, P57057, P70553, Q0D7E4, Q27946, Q27981, Q5M7K3, Q5R6B8, Q5R839, Q653V6, Q6DIV6, Q6PF45, Q6YK44, Q86UD5, Q8AVC3, Q8BJA2, Q8CH36, Q8H4H5, Q8IVJ1, Q8L4X4
Diamond homologs: O23596, P57057, Q17QZ3, Q3TIT8, Q58CV5, Q5F3N0, Q5M7K3, Q640L2, Q7SY29, Q8AVC3, Q8NCC5, Q8R070, Q8TED4, Q9C5L3, Q9SA71, Q9SB41, Q9SL56, Q9WU81, P42205, P9WG86, P9WG87
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
137 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 85 |
| Likely benign | 15 |
| Benign | 10 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4321 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:42539510:A:AG | acceptor_gain | 1.0000 |
| 21:42539511:G:GC | acceptor_gain | 1.0000 |
| 21:42539511:GTGGC:G | acceptor_gain | 1.0000 |
| 21:42539644:TCAGG:T | donor_loss | 1.0000 |
| 21:42539647:GGT:G | donor_loss | 1.0000 |
| 21:42539648:G:GC | donor_loss | 1.0000 |
| 21:42539649:T:G | donor_loss | 1.0000 |
| 21:42542476:GGAAG:G | donor_gain | 1.0000 |
| 21:42542477:GAAGG:G | donor_gain | 1.0000 |
| 21:42542478:A:T | donor_gain | 1.0000 |
| 21:42542478:AAGGT:A | donor_loss | 1.0000 |
| 21:42542479:AGGTG:A | donor_loss | 1.0000 |
| 21:42542482:T:G | donor_loss | 1.0000 |
| 21:42554058:CCA:C | acceptor_loss | 1.0000 |
| 21:42554059:CAGC:C | acceptor_loss | 1.0000 |
| 21:42554060:A:AG | acceptor_gain | 1.0000 |
| 21:42554060:AG:A | acceptor_loss | 1.0000 |
| 21:42554061:G:GA | acceptor_gain | 1.0000 |
| 21:42554061:GC:G | acceptor_gain | 1.0000 |
| 21:42554061:GCA:G | acceptor_gain | 1.0000 |
| 21:42554141:TGGTA:T | donor_loss | 1.0000 |
| 21:42554142:GGTA:G | donor_loss | 1.0000 |
| 21:42554143:GTAA:G | donor_loss | 1.0000 |
| 21:42554144:T:G | donor_loss | 1.0000 |
| 21:42558941:A:AG | acceptor_gain | 1.0000 |
| 21:42558941:AAT:A | acceptor_gain | 1.0000 |
| 21:42558941:AATG:A | acceptor_gain | 1.0000 |
| 21:42558942:A:G | acceptor_gain | 1.0000 |
| 21:42558942:AT:A | acceptor_gain | 1.0000 |
| 21:42558942:ATG:A | acceptor_gain | 1.0000 |
AlphaMissense
3461 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:42543458:T:A | W196R | 0.999 |
| 21:42543458:T:C | W196R | 0.999 |
| 21:42562103:T:C | L336P | 0.999 |
| 21:42525835:G:C | R39P | 0.998 |
| 21:42562090:T:C | F332L | 0.998 |
| 21:42562092:C:A | F332L | 0.998 |
| 21:42562092:C:G | F332L | 0.998 |
| 21:42568430:G:A | G472D | 0.998 |
| 21:42568438:G:A | G475R | 0.998 |
| 21:42568438:G:C | G475R | 0.998 |
| 21:42574818:G:A | G475E | 0.998 |
| 21:42535516:T:C | F106L | 0.997 |
| 21:42535518:C:A | F106L | 0.997 |
| 21:42535518:C:G | F106L | 0.997 |
| 21:42542434:T:A | W173R | 0.997 |
| 21:42542434:T:C | W173R | 0.997 |
| 21:42562118:T:C | L341P | 0.997 |
| 21:42562145:T:C | L350P | 0.997 |
| 21:42567045:T:A | V444D | 0.997 |
| 21:42568411:G:C | A466P | 0.997 |
| 21:42568415:T:A | I467N | 0.997 |
| 21:42568423:G:T | G470W | 0.997 |
| 21:42568424:G:A | G470E | 0.997 |
| 21:42568429:G:C | G472R | 0.997 |
| 21:42574824:C:A | A477D | 0.997 |
| 21:42574829:G:C | G479R | 0.997 |
| 21:42525846:A:C | S43R | 0.996 |
| 21:42525848:C:A | S43R | 0.996 |
| 21:42525848:C:G | S43R | 0.996 |
| 21:42525853:T:A | V45D | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000018467 (21:42529975 C>G), RS1000023546 (21:42570332 G>A), RS1000074876 (21:42543943 G>C), RS1000098294 (21:42513134 C>A), RS1000164827 (21:42506639 C>T), RS1000221949 (21:42540902 C>G), RS1000226812 (21:42575356 C>T), RS1000230730 (21:42540640 G>C), RS1000240230 (21:42524565 G>T), RS1000271360 (21:42551182 A>G,T), RS1000339320 (21:42580947 T>C,G), RS1000367473 (21:42500762 T>G), RS1000371793 (21:42580685 G>A,C,T), RS1000376629 (21:42546523 C>T), RS1000393520 (21:42509579 G>A)
Disease associations
OMIM: gene MIM:608094 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs35112095 | SLC37A1 | 0.00 | 0 |
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC37 family of phosphosugar/phosphate exchangers
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| manganese chloride | increases expression, increases abundance | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| nickel sulfate | increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| 3-nitrobenzanthrone | decreases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | increases expression | 1 |
| 3-iodothyronamine | affects uptake | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Tretinoin | increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Zidovudine | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
7 cell lines: 7 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_1252 | HCC1428 | Cancer cell line | Female |
| CVCL_C9DB | HCC1428/Cas9-hyg | Cancer cell line | Female |
| CVCL_D4VX | LS180-SLC37A1-KO-c2 | Cancer cell line | Female |
| CVCL_D4VY | LS180-SLC37A1-KO-c3 | Cancer cell line | Female |
| CVCL_TN36 | HAP1 SLC37A1 (-) 1 | Cancer cell line | Male |
| CVCL_XT29 | HAP1 SLC37A1 (-) 2 | Cancer cell line | Male |
| CVCL_YX83 | HCC1428-LTED | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.